SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-005450
Filing Date
2022-01-28
Accepted
2022-01-28 17:04:34
Documents
1
Period of Report
2022-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4147
  Complete submission text file 0001209191-22-005450.txt   5520
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL NEUROPHARMA INC (Issuer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 555 CALIFORNIA STREET SUITE 365 SAN FRANCISCO CA 94104
Business Address
Leaman John Harold (Reporting) CIK: 0001586657 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40353 | Film No.: 22569851